November 7, 2016 / 2:33 PM / 10 months ago

BRIEF-Rexahn Pharmaceuticals reports Q3 loss per share of $0.01

Nov 7 (Reuters) - Rexahn Pharmaceuticals Inc

* Rexahn Pharma - expects cash, investments as of Sept 30, 2016 to be sufficient to fund cash flow requirements for activities into first half of 2018

* Rexahn Pharmaceuticals reports third quarter 2016 financial results and provides corporate update

* Q3 loss per share $0.01 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below